Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: THE UNITED STATES PHARMACOPEIAL CONVENTION, THE UNITED STATES PHARMACOPEIAL CONVENTION, INC., THE UNITED STATES PHARMACOPEIAL CONVENTION
Client-Reported Lobbying Expenses
$5.7M
88 filings
Firm Income Reported for This Client
$360K
Not substituted for client expenses
Contract Awards
$2.0M
72 awards
Summary
THE UNITED STATES PHARMACOPEIAL CONVENTION is an organization, based in MD. Its political footprint includes $5.7 million in client-reported lobbying expenses, $360K in lobbying-firm income reported for this client, $2.0 million in government contracts. Lobbying activity focuses on Health Issues, Pharmacy, Food Industry (safety, labeling, etc.), Consumer Issues/Safety/Products. Their largest government contract source is Department of Defense at $928K. Political activity spans from 2007 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↑ 50% YoY
2025: $360K (complete years)
Political Money Flow
Government agencies → THE UNITED STATES PHAR... (contracts) → political recipients & lobbying. Hover for details.
Activity data: Senate LDA · USAspending.gov